TY - JOUR
T1 - Patient-level and system-level determinants of stroke fatality across 16 large hospitals in Ghana and Nigeria
T2 - a prospective cohort study
AU - SIREN
AU - Sarfo, Fred S.
AU - Akpa, Onoja M.
AU - Ovbiagele, Bruce
AU - Akpalu, Albert
AU - Wahab, Kolawole
AU - Obiako, Reginald
AU - Komolafe, Morenikeji
AU - Owolabi, Lukman
AU - Ogbole, Godwin
AU - Fakunle, Adekunle
AU - Okekunle, Akinkunmi Paul
AU - Asowata, Osahon J.
AU - Calys-Tagoe, Benedict
AU - Uvere, Ezinne O.
AU - Sanni, Taofeek
AU - Olowookere, Samuel
AU - Ibinaiye, Philip
AU - Akinyemi, Joshua O.
AU - Arulogun, Oyedunni
AU - Jenkins, Carolyn
AU - Lackland, Daniel T.
AU - Tiwari, Hemant K.
AU - Isah, Suleiman Y.
AU - Abubakar, Sani A.
AU - Oladimeji, Adebayo
AU - Adebayo, Philip
AU - Akpalu, Josephine
AU - Onyeonoro, Ugochukwu
AU - Ogunmodede, James A.
AU - Akisanya, Cynthia
AU - Mensah, Yaw
AU - Oyinloye, Olalekan I.
AU - Appiah, Lambert
AU - Agunloye, Atinuke M.
AU - Osaigbovo, Godwin O.
AU - Adeoye, Abiodun M.
AU - Adeleye, Osimhiarherhuo Ohifemen
AU - Laryea, Ruth Y.
AU - Olunuga, Taiwo
AU - Ogah, Okechukwu S.
AU - Oguike, Wisdom
AU - Ogunronbi, Mayowa
AU - Adeniyi, Wasiu
AU - Olugbo, Obiabo Y.
AU - Bello, Abiodun H.
AU - Ogunjimi, Luqman
AU - Diala, Samuel
AU - Dambatta, Hamisu A.
AU - Singh, Arti
AU - Adamu, Sheila
N1 - Publisher Copyright:
© 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license
PY - 2023/4
Y1 - 2023/4
N2 - Background: Every minute, six indigenous Africans develop new strokes. Patient-level and system-level contributors to early stroke fatality in this region are yet to be delineated. We aimed to identify and quantify the contributions of patient-level and system-level determinants of inpatient stroke fatality across 16 hospitals in Ghana and Nigeria. Methods: The Stroke Investigative Research and Educational Network (SIREN) is a multicentre study involving 16 sites in Ghana and Nigeria. Cases include adults (aged ≥18 years) with clinical and radiological evidence of an acute stroke. Data on stroke services and resources available at each study site were collected and analysed as system-level factors. A host of demographic and clinical variables of cases were analysed as patient-level factors. A mixed effect log-binomial model including both patient-level and system-level covariates was fitted. Results are presented as adjusted risk ratios (aRRs) with respective 95% CIs. Findings: Overall, 814 (21·8%) of the 3739 patients admitted with stroke died as inpatients: 476 (18·1%) of 2635 with ischaemic stroke and 338 (30·6%) of 1104 with intracerebral haemorrhage. The variability in the odds of stroke fatality that could be attributed to the system-level factors across study sites assessed using model intracluster correlation coefficient was substantial at 7·3% (above a 5% threshold). Stroke units were available at only five of 16 centres. The aRRs of six patient-level factors associated with stroke fatality were: low vegetable consumption, 1·19 (95% CI 1·07–1·33); systolic blood pressure, 1·02 (1·01–1·04) for each 10 mm Hg rise; stroke lesion volume more than 30 cm3, 1·48 (1·22–1·79); National Institutes of Health Stroke Scale (NIHSS) score, 1·20 (1·13–1·26) for each 5-unit rise; elevated intracranial pressure, 1·75 (1·31–2·33); and aspiration pneumonia, 1·79 (1·16–2·77). Interpretation: Studies are needed to assess the efficacy of interventions targeting patient-level factors such as aspiration pneumonia in reducing acute stroke fatality in this region. Policy directives to improve stroke unit access are warranted. Funding: US National Institutes of Health. Translations: For the Twi, Yoruba and Hausa translations of the abstract see Supplementary Materials section.
AB - Background: Every minute, six indigenous Africans develop new strokes. Patient-level and system-level contributors to early stroke fatality in this region are yet to be delineated. We aimed to identify and quantify the contributions of patient-level and system-level determinants of inpatient stroke fatality across 16 hospitals in Ghana and Nigeria. Methods: The Stroke Investigative Research and Educational Network (SIREN) is a multicentre study involving 16 sites in Ghana and Nigeria. Cases include adults (aged ≥18 years) with clinical and radiological evidence of an acute stroke. Data on stroke services and resources available at each study site were collected and analysed as system-level factors. A host of demographic and clinical variables of cases were analysed as patient-level factors. A mixed effect log-binomial model including both patient-level and system-level covariates was fitted. Results are presented as adjusted risk ratios (aRRs) with respective 95% CIs. Findings: Overall, 814 (21·8%) of the 3739 patients admitted with stroke died as inpatients: 476 (18·1%) of 2635 with ischaemic stroke and 338 (30·6%) of 1104 with intracerebral haemorrhage. The variability in the odds of stroke fatality that could be attributed to the system-level factors across study sites assessed using model intracluster correlation coefficient was substantial at 7·3% (above a 5% threshold). Stroke units were available at only five of 16 centres. The aRRs of six patient-level factors associated with stroke fatality were: low vegetable consumption, 1·19 (95% CI 1·07–1·33); systolic blood pressure, 1·02 (1·01–1·04) for each 10 mm Hg rise; stroke lesion volume more than 30 cm3, 1·48 (1·22–1·79); National Institutes of Health Stroke Scale (NIHSS) score, 1·20 (1·13–1·26) for each 5-unit rise; elevated intracranial pressure, 1·75 (1·31–2·33); and aspiration pneumonia, 1·79 (1·16–2·77). Interpretation: Studies are needed to assess the efficacy of interventions targeting patient-level factors such as aspiration pneumonia in reducing acute stroke fatality in this region. Policy directives to improve stroke unit access are warranted. Funding: US National Institutes of Health. Translations: For the Twi, Yoruba and Hausa translations of the abstract see Supplementary Materials section.
UR - http://www.scopus.com/inward/record.url?scp=85149625833&partnerID=8YFLogxK
U2 - 10.1016/S2214-109X(23)00038-4
DO - 10.1016/S2214-109X(23)00038-4
M3 - Article
C2 - 36805867
AN - SCOPUS:85149625833
SN - 2214-109X
VL - 11
SP - e575-e585
JO - The Lancet Global Health
JF - The Lancet Global Health
IS - 4
ER -